Temasek-backed Chinese biotech firm Innovent raises $421m in HK IPO

Temasek-backed Chinese biotech firm Innovent raises $421m in HK IPO

24 October, 2018

Fidelity Innovent Biologics Temasek

Printed by Unregistered user on Fri, 24 Oct 2025 19:33:46 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from Greater China

China’s e-commerce boom drives rapid robovan adoption

Sany Heavy Industry raises $1.6b in Hong Kong listing